These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30084325)

  • 1. Nanostructured Hyaluronic Acid-based Materials for the Delivery of siRNA.
    Shah K; Chawla S; Gadeval A; Reddy G; Maheshwari R; Kalia K; Tekade RK
    Curr Pharm Des; 2018; 24(23):2678-2691. PubMed ID: 30084325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of siRNA Nanosheets for Efficient RNA Interference.
    Kim H; Lee JS; Lee JB
    Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
    Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
    Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.
    Tirella A; Kloc-Muniak K; Good L; Ridden J; Ashford M; Puri S; Tirelli N
    Int J Pharm; 2019 Apr; 561():114-123. PubMed ID: 30822503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
    Lorenzer C; Dirin M; Winkler AM; Baumann V; Winkler J
    J Control Release; 2015 Apr; 203():1-15. PubMed ID: 25660205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA delivery to liver sinusoidal endothelium with polyethylenimine grafted hyaluronic acid.
    Lin L; Cai M; Deng S; Huang W; Huang J; Huang X; Huang M; Wang Y; Shuai X; Zhu K
    Nanomedicine; 2017 Oct; 13(7):2329-2339. PubMed ID: 28712920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Liposomes for siRNA Delivery to Cancer.
    Eloy JO; Petrilli R; Raspantini GL; Lee RJ
    Curr Pharm Des; 2018; 24(23):2664-2672. PubMed ID: 30084323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
    Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
    Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy.
    Lee SK; Law B; Tung CH
    Methods Mol Biol; 2020; 2115():79-90. PubMed ID: 32006395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
    ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-Based Nanocarriers for RNA Delivery.
    Xue HY; Guo P; Wen WC; Wong HL
    Curr Pharm Des; 2015; 21(22):3140-7. PubMed ID: 26027572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
    Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
    Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment.
    Yalcin E; Kara G; Celik E; Pinarli FA; Saylam G; Sucularli C; Ozturk S; Yilmaz E; Bayir O; Korkmaz MH; Denkbas EB
    Prep Biochem Biotechnol; 2019; 49(7):659-670. PubMed ID: 31066619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.